Agio Pharmaceuticals Limited
Indian Pharmaceutical Exporter ยท Respiratory & OTC Specialist ยท $11.9M Total Trade ยท DGFT Verified
Agio Pharmaceuticals Limited is an Indian pharmaceutical exporter with a total trade value of $11.9M across 15 products in 8 therapeutic categories. Based on 726 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Dexamethasone ($1.9M), Phenylephrine ($1.8M), Clotrimazole ($1.4M).
Agio Pharmaceuticals Limited โ Export Portfolio & Destination Treemap

Who is Agio Pharmaceuticals Limited? โ Company Overview & Market Position
Agio Pharmaceuticals Limited, established in 1991, is a privately held Indian pharmaceutical company headquartered in Mumbai, Maharashtra. The company is registered under the Corporate Identification Number (CIN) U24239MH1992PLC065031. As of the latest available data, Agio Pharmaceuticals has an authorized capital of โน60 million and a paid-up capital of โน51.85 million. The company operates in the manufacturing sector, focusing on the production of pharmaceutical and medicinal products.
Agio Pharmaceuticals Limited has a diverse product portfolio encompassing 15 products across eight therapeutic categories. The company's total export value stands at $11.9 million USD, with 726 shipments recorded. The top five exported products include Dexamethasone ($1.9 million), Phenylephrine ($1.8 million), Clotrimazole ($1.4 million), Prednisolone ($1.3 million), and Salbutamol ($1.2 million). These products are primarily categorized under Respiratory & OTC (30.8%), Respiratory (21.4%), and Antifungals (19.4%). Notably, the top five products contribute to 64.4% of the company's total export value, indicating a moderate level of portfolio concentration.